top of page

News

SENSY: Groundbreaking Technology for Diabetic Neuropathy

Neurotech Reports highlights Sensars as an emerging company with groundbreaking technology for the treatment of painful diabetic neuropathy.  Read More > 

Sensars gets funding of €1.1M to advance its SENSY product 

Lausanne, Munich, May 2024 – Sensars, a pioneering leader in neuromodulation technology, is proud to announce significant advancements in its mission to revolutionize the treatment of chronic pain and sensory loss. Read More >

Sensars coordinates a €3 million grant to test its bionic prosthetics

Sensars has received a 3 million EUR grant as part of the European Union’s Horizon Research and Innovation program. The startup will coordinate and use the funds to further develop and test its product - the neuroprosthetic system. Read More >

Top '20 Most Innovative Companies to Watch, 2022

Sensars Named In Business Worldwide Magazines' Top '20 Most Innovative Companies to Watch, 2022. Read More > 

Sensars receives FDA Breakthrough Device Designation

Two Swiss start-ups have been granted FDA Breakthrough Device Designation recently: AMF for its Sigi Insulin Management system and Sensars for its system providing sensory feedback for those with limb loss to improve prosthesis function.  Read More > 

Our Partners

We have established deep partnerships with the world's most prestigious institutions, clinics and accelerators.

We have also been granted numerous global awards for our breakthrough technology. 

Clinical Partnerships

Academic & Industrial Partners

Grants & Awards

Neuralive Brand Book (10).png

Sensars is designed to restore protective sensations to prevent complications of diabetic neuropathy

Looking Ahead

Neurotech of the future

Our neurotechnology creates countless new possibilities in the future, from prosthetic control to obesity & depression treatment & beyond.

Reviving Sensation, Restoring Life

Revolutionizing Neuromodulation for Treatment of Diabetic Neuropathy

Feel whole again

The only device able to restore sensations to limbs

By stimulating the peripheral nervous system, our unique technology revives communication between nerve damaged areas and the brain to lower risks of diabetic neuropathy complications.

Traction

Breakthrough device designation

​Successful human clinical trials

​25+ Peer reviewed publications

Diabetic Neuropathy affects millions of patients globally

 

Today, no existing solutions address the core cause of diabetic neuropathy complications; a disrupted sensory feedback loop.

Sensars is the only technology designed to completely restore sensory feedback to the extremities with high specificity and coverage.

disrupted sensory loop v3.png

How diabetic neuropathy works

How we reduce risks of complications

restored sensory loop v3.png

How our closed loop system works

Sensors under the diabetic foot

Wearable sensors detect information of touch and movement from the foot and transmit it wirelessly to electrodes implanted inside the nerve.

Electrodes are implanted in the nerve

The intra-nerve electrode array is implanted inside the peripheral nerve accessing all the sensory fibers to reconstruct healthy nerve signals to the brain.

Sensory feedback is restored

​Healthy nerve signals restore protective foot sensations to lower risk of falls, ulcers and amputation.

bottom of page